Neurocognitive effects of atypical and conventional antipsychotic drugs in schizophrenia: A naturalistic 6-month follow-up study

Archives of Clinical Neuropsychology

Volumn 23, Issue 3, 2008, Pages 271-282

  Wittorf, Andreas ^a   Sickinger, Stephanie ^a   Wiedemann, Georg ^b   Klingberg, Stefan ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Drug effects; Follow up study; Neurocognition; Non randomized; Schizophrenia

Indexed keywords

AMISULPRIDE; ATYPICAL ANTIPSYCHOTIC AGENT; BROMPERIDOL; CHLORPROTHIXENE; CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PERAZINE; PERPHENAZINE; PROMETHAZINE; RISPERIDONE; SULPIRIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; MALE; PATIENT COMPLIANCE; SCHIZOPHRENIA;

EID: 42649084332     PISSN: 08876177     EISSN: 18735843     Source Type: Journal    
DOI: 10.1016/j.acn.2007.12.005     Document Type: Article

References (44)